ImmunityBio
IBRX
IBRX
68 hedge funds and large institutions have $92.1M invested in ImmunityBio in 2016 Q4 according to their latest regulatory filings, with 14 funds opening new positions, 20 increasing their positions, 15 reducing their positions, and 8 closing their positions.
New
Increased
Maintained
Reduced
Closed
more first-time investments, than exits
New positions opened: | Existing positions closed:
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more ownership
Funds ownership: →
more funds holding
Funds holding: →
1% more call options, than puts
Call options by funds: $80K | Put options by funds: $79K
41% less capital invested
Capital invested by funds: $155M → $92.1M (-$62.8M)
50% less funds holding in top 10
Funds holding in top 10: 2 → 1 (-1)
Holders
68
Holding in Top 10
1
Calls
$80K
Puts
$79K
Top Buyers
| 1 | +$832K | |
| 2 | +$811K | |
| 3 | +$504K | |
| 4 |
Susquehanna International Group
Bala Cynwyd,
Pennsylvania
|
+$304K |
| 5 |
Morgan Stanley
New York
|
+$280K |
Top Sellers
| 1 | -$26.5M | |
| 2 | -$5.32M | |
| 3 | -$822K | |
| 4 |
ACA
Avoro Capital Advisors
New York
|
-$563K |
| 5 |
VEA
Virtus ETF Advisers
New York
|
-$295K |